GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Magnasense AB (OSTO:MAGNA) » Definitions » Ending Cash Position

Magnasense AB (OSTO:MAGNA) Ending Cash Position : kr0.28 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magnasense AB Ending Cash Position?

Magnasense AB's Ending Cash Position for the quarter that ended in Dec. 2024 was kr0.28 Mil.

Magnasense AB's quarterly Ending Cash Position declined from Jun. 2024 (kr2.36 Mil) to Sep. 2024 (kr1.79 Mil) and declined from Sep. 2024 (kr1.79 Mil) to Dec. 2024 (kr0.28 Mil).

Magnasense AB's annual Ending Cash Position declined from Dec. 2022 (kr14.59 Mil) to Dec. 2023 (kr12.14 Mil) and declined from Dec. 2023 (kr12.14 Mil) to Dec. 2024 (kr0.28 Mil).


Magnasense AB Ending Cash Position Historical Data

The historical data trend for Magnasense AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magnasense AB Ending Cash Position Chart

Magnasense AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 10.40 34.03 14.59 12.14 0.28

Magnasense AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.14 0.23 2.36 1.79 0.28

Magnasense AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Magnasense AB's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=12.142+-11.859
=0.28

Magnasense AB's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.792+-1.509
=0.28


Magnasense AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Magnasense AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Magnasense AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.

Magnasense AB Headlines

No Headlines